Eukaryotic Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
EC.00151-07v1
6/10/1889    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coste, A.
Right arrow Articles by Sanglard, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coste, A.
Right arrow Articles by Sanglard, D.

 Previous Article  |  Next Article 

Eukaryotic Cell, October 2007, p. 1889-1904, Vol. 6, No. 10
1535-9778/07/$08.00+0     doi:10.1128/EC.00151-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates{triangledown} ,{dagger}

Alix Coste,1 Anna Selmecki,2 Anja Forche,2 Dorothée Diogo,3 Marie-Elisabeth Bougnoux,3 Christophe d'Enfert,3 Judith Berman,2 and Dominique Sanglard1*

Institute of Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerland,1 Department of Microbiology, University of Minnesota, Minneapolis, Minnesota,2 Unité Biologie et Pathogénicité Fongiques, INRA USC2019, Département Génomes et Génétique, Institut Pasteur, Paris, France3

Received 30 April 2007/ Accepted 20 July 2007

TAC1 (for transcriptional activator of CDR genes) is critical for the upregulation of the ABC transporters CDR1 and CDR2, which mediate azole resistance in Candida albicans. While a wild-type TAC1 allele drives high expression of CDR1/2 in response to inducers, we showed previously that TAC1 can be hyperactive by a gain-of-function (GOF) point mutation responsible for constitutive high expression of CDR1/2. High azole resistance levels are achieved when C. albicans carries hyperactive alleles only as a consequence of loss of heterozygosity (LOH) at the TAC1 locus on chromosome 5 (Chr 5), which is linked to the mating-type-like (MTL) locus. Both are located on the Chr 5 left arm along with ERG11 (target of azoles). In this work, five groups of related isolates containing azole-susceptible and -resistant strains were analyzed for the TAC1 and ERG11 alleles and for Chr 5 alterations. While recovered ERG11 alleles contained known mutations, 17 new TAC1 alleles were isolated, including 7 hyperactive alleles with five separate new GOF mutations. Single-nucleotide-polymorphism analysis of Chr 5 revealed that azole-resistant strains acquired TAC1 hyperactive alleles and, in most cases, ERG11 mutant alleles by LOH events not systematically including the MTL locus. TAC1 LOH resulted from mitotic recombination of the left arm of Chr 5, gene conversion within the TAC1 locus, or the loss and reduplication of the entire Chr 5. In one case, two independent TAC1 hyperactive alleles were acquired. Comparative genome hybridization and karyotype analysis revealed the presence of isochromosome 5L [i(5L)] in two azole-resistant strains. i(5L) leads to increased copy numbers of azole resistance genes present on the left arm of Chr 5, among them TAC1 and ERG11. Our work shows that azole resistance was due not only to the presence of specific mutations in azole resistance genes (at least ERG11 and TAC1) but also to their increase in copy number by LOH and to the addition of extra Chr 5 copies. With the combination of these different modifications, sophisticated genotypes were obtained. The development of azole resistance in C. albicans is therefore a powerful instrument for generating genetic diversity.

* Corresponding author. Mailing address: Institute of Microbiology, University of Lausanne and University Hospital Center, Rue du Bugnon 48, CH-1011 Lausanne, Switzerland. Phone: 41 21 314 40 83. Fax: 41 21 314 40 60. E-mail: Dominique.Sanglard{at}chuv.ch

{triangledown} Published ahead of print on 10 August 2007.

{dagger} Supplemental material for this article may be found at http://ec.asm.org/.

Eukaryotic Cell, October 2007, p. 1889-1904, Vol. 6, No. 10
1535-9778/07/$08.00+0     doi:10.1128/EC.00151-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Appl. Environ. Microbiol. Infect. Immun. J. Bacteriol.
Mol. Cell Biol. Microbiol. Mol. Biol. Rev. ALL ASM JOURNALS
Copyright © 2007 by the American Society for Microbiology.